4//SEC Filing
Caladrius Biosciences, Inc. 4
Accession 0001144204-17-006290
$LSTACIK 0000320017operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:47 PM ET
Size
12.5 KB
Accession
0001144204-17-006290
Insider Transaction Report
Form 4
Wei Eric
Director
Transactions
- Sale
Common Stock
2017-02-02$4.51/sh−5,000$22,547→ 182,223 total(indirect: See Footnote) - Sale
Common Stock
2017-02-02$4.75/sh−1,400$6,651→ 180,823 total(indirect: See Footnote) - Sale
Common Stock
2017-02-03$4.76/sh−1,525$7,256→ 179,298 total(indirect: See Footnote) - Sale
Common Stock
2017-02-06$4.75/sh−500$2,375→ 178,798 total(indirect: See Footnote)
Holdings
- 4,300
Common Stock
Footnotes (4)
- [F1]The transactions reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as of June 3, 2016.
- [F2]Following the reported transactions, 177,598 shares of Common Stock of the Issuer are held by RimAsia Capital Partners L.P., a Cayman Islands exempted limited partnership ("RimAsia LP"), and 1,200 shares of Common Stock of the Issuer are held by RimAsia Capital Partners Manager, Ltd., a Cayman Islands exempted company ("RimAsia Manager").
- [F3]RimAsia Capital Partners GP, L.P., a Cayman Islands exempted limited partnership ("RimAsia GP"), is the general partner of RimAsia LP. RimAsia Manager is the Fund Manager of RimAsia GP and the Manager of RimAsia LP. Mr. Wei is the managing partner of RimAsia LP, an indirect partner of RimAsia GP, a director of RimAsia Capital Partners GP, Ltd. and a director of RimAsia Manager. As a result, Mr. Wei may be deemed to have sole power to vote certain of the securities held by RimAsia LP and RimAsia Manager. Mr. Wei disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and the inclusion of these securities shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Securities Exchange Act or for any other purpose.
- [F4]Includes 2,775 shares of unvested restricted stock granted under the Issuer's compensation plans.
Documents
Issuer
Caladrius Biosciences, Inc.
CIK 0000320017
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000320017
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 7:47 PM ET
- Size
- 12.5 KB